ELUT Elutia Corp: רווח למניה ב-12 החודשים האחרונים

Elutia Inc. (ELUT) develops biological implants that ensure stable demand driven by physician trust and therapy standards. This chart illustrates the asset's market value, reflecting an EPS TTM of 7.60. The business relies on supplies to various global clinics specializing in cardiology and orthopedics, while strictly adhering to bio-waste disposal regulations and minimizing environmental impact.
פילוחי מדדים פיננסיים ומדדי שוק עבור Elutia Corporation (ELUT)

To minimize fundamental risks, investors should select assets with sustainable positive earnings per share growth. This metric measures the percentage change in EPS over the last twelve months, reflecting the scaling rate of net income relative to previous periods. For Elutia Inc. (ELUT), this confirms the commercial efficiency of its implant innovations, as clearly demonstrated by the annual EPS TTM percentage growth chart.